372 related articles for article (PubMed ID: 27821204)
1. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
[TBL] [Abstract][Full Text] [Related]
2. Cannabis abuse and risk for psychosis in a prodromal sample.
Kristensen K; Cadenhead KS
Psychiatry Res; 2007 May; 151(1-2):151-4. PubMed ID: 17383738
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
[TBL] [Abstract][Full Text] [Related]
4. [Cannabis use in subjects at ultra high risk for psychosis].
Fekih-Romdhane F; Hakiri A; Fadhel SB; Cheour M
Presse Med; 2019 Nov; 48(11 Pt 1):1229-1236. PubMed ID: 31732360
[TBL] [Abstract][Full Text] [Related]
5. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.
Henquet C; Krabbendam L; Spauwen J; Kaplan C; Lieb R; Wittchen HU; van Os J
BMJ; 2005 Jan; 330(7481):11. PubMed ID: 15574485
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use and transition to psychosis in people at ultra-high risk.
Valmaggia LR; Day FL; Jones C; Bissoli S; Pugh C; Hall D; Bhattacharyya S; Howes O; Stone J; Fusar-Poli P; Byrne M; McGuire PK
Psychol Med; 2014 Sep; 44(12):2503-12. PubMed ID: 25055169
[TBL] [Abstract][Full Text] [Related]
7. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
8. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
9. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
Kuepper R; van Os J; Lieb R; Wittchen HU; Höfler M; Henquet C
BMJ; 2011 Mar; 342():d738. PubMed ID: 21363868
[TBL] [Abstract][Full Text] [Related]
10. [The role of cannabis use in psychosis].
Pajkossy P; Demetrovics Z
Psychiatr Hung; 2007; 22(2):145-62. PubMed ID: 17895537
[TBL] [Abstract][Full Text] [Related]
11. Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.
Cropley VL; Lin A; Nelson B; Reniers RLEP; Yung AR; Bartholomeusz CF; Klauser P; Velakoulis D; McGorry P; Wood SJ; Pantelis C
Schizophr Res; 2016 Jun; 173(3):152-158. PubMed ID: 26032566
[TBL] [Abstract][Full Text] [Related]
12. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
[TBL] [Abstract][Full Text] [Related]
13. Cannabis use predicts future psychotic symptoms, and vice versa.
Ferdinand RF; Sondeijker F; van der Ende J; Selten JP; Huizink A; Verhulst FC
Addiction; 2005 May; 100(5):612-8. PubMed ID: 15847618
[TBL] [Abstract][Full Text] [Related]
14. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
Nelson B; Yuen K; Yung AR
Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
[TBL] [Abstract][Full Text] [Related]
16. What every adolescent needs to know: cannabis can cause psychosis.
Shapiro GK; Buckley-Hunter L
J Psychosom Res; 2010 Dec; 69(6):533-9. PubMed ID: 21109040
[TBL] [Abstract][Full Text] [Related]
17. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.
Dragt S; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; de Haan L; van Amelsvoort TA; Linszen DH
Can J Psychiatry; 2010 Mar; 55(3):165-71. PubMed ID: 20370967
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
19. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.
Rolland B; Geoffroy PA; Jardri R; Cottencin O
Clin Neuropharmacol; 2013; 36(3):98-9. PubMed ID: 23673914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
